Results 161 to 170 of about 122,296 (281)

Short‐Term Adverse Events Following Recombinant Zoster Vaccination in Older Adults in Australia: A Survey Study Comparing Dose 1 and Dose 2 and Influence of Dose Interval

Medical Journal of Australia, Volume 224, Issue 11, November 2026.
ABSTRACT Self‐reported adverse events following first and second recombinant zoster vaccination (RZV) doses in older adults (n = 41,069) collected through AusVaxSafety were analysed. Adverse event rates were higher following Dose 2 (54%; 95% CI, 53%–54%) than after Dose 1 (45%; 95% CI, 45%–46%), particularly with 3–6‐ and 7–9‐month dose intervals ...
Lucy Dawes, Thuy Nguyen, Kristine Macartney, Lucy Deng   +3 more
wiley   +1 more source

Uncommon Presentation of Genital Herpes Zoster. [PDF]

Indian Dermatol Online J
Gupta P, Narang T, De D.
europepmc   +1 more source

Herpes zoster in Australia [PDF]

Epidemiology and Infection, 2011
K S, Carville, K A, Grant, H A, Kelly
openaire   +2 more sources

Severe atypical herpes zoster as an initial symptom of fatal myelodysplastic syndrome with refractory anemia and blast excess (RAEB II)

, 2017
Uwe Wollina,1 Gesina Hansel,1 Anja Baunacke,1 Georgi Tchernev2 1Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany; 2Department of Dermatology and Dermatologic Surgery, Medical Institute of ...
Wollina U, Tchernev G, Hansel G, Baunacke A   +3 more
core  

Sustained Delivery of a Shingles Subunit Vaccine Overcomes Age‐Related Declines in Humoral and Cellular Immunity Relative to Shingrix

Advanced Science, Volume 13, Issue 60, 28 October 2026.
Sustained delivery of a shingles subunit vaccine from an injectable polymer–nanoparticle hydrogel enhanced the potency, durability, and breadth of immune responses in aged mice while minimizing inflammatory cytokine production and reactogenicity. This strategy decouples immunogenicity from reactogenicity and offers a promising approach to improve ...
Ye Eun Song, Jerry Yan, Ben S. Ou, Olivia M. Saouaf, Noah Eckman, E. A. Appel   +5 more
wiley   +1 more source

Development of mRNA vaccines against herpes zoster. [PDF]

Hum Vaccin Immunother
Li D, Luo J, Wang J, Wang L, Zhang M, Shen J, Chu X, Mao W, Zhang Y, Xin H.   +9 more
europepmc   +1 more source

Herpes zoster optic neuritis: a catastrophe of a disease

Isolated herpes zoster optic neuritis is a rare sequelae of herpes zoster ophthalmicus (HZO). It can occur in the acute phase of HZO, or as post-herpetic complications.
Mohd Isa, Muhammad, Md Saleh, Rafidah, Mohd Zaidan, Khairun Nisa, Mohammad Razali, Amirah, Md Noh, Mohamad Syafeeq Faeez   +4 more
core   +1 more source

Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting

British Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3333-3353, October 2026.
Chronic pain represents a complex debilitating condition that extends beyond the protective function of physiological pain, often persisting as an independent disease entity. Chronic primary and secondary pain syndromes reflect a multifaceted continuum involving nociceptive, neuropathic and nociplastic mechanisms.
Stefania Nobili, Maurizio Evangelista, Elena Lucarini, Elena G. Giugliano, Carla Ghelardini, Laura Micheli, Lorenzo Di Cesare Mannelli   +6 more
wiley   +1 more source

Efficacy and Effectiveness of the Recombinant Zoster Vaccine Against Herpes Zoster, Herpes Zoster Ophthalmicus, Postherpetic Neuralgia and Dementia: A Systematic Review and Meta-Analysis. [PDF]

Rev Med Virol
Heen E, Øverbø J, Tveteraas IH, Solberg SL, Nøkleby H, Midtbø JE, Di Rusco F, Kasteng F, Ersson A, Andersson S, Johansen K, Juvet LK.   +11 more
europepmc   +1 more source

CO‐Rebreathing in Essential Thrombocythemia and Polycythemia Vera. A Revival of an Old Methodology to Improve Diagnosis and Phlebotomy Decisions

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT The diagnostic landscape for the Philadelphia‐negative myeloproliferative neoplasms (MPNs), particularly in distinguishing Essential Thrombocythemia (ET) from Polycythemia Vera (PV), is compromised. The gold standard for diagnosing PV—measurement of red cell mass (RCM) by radioisotope dilution—has been largely abandoned, leading to widespread ...
Hans C. Hasselbalch, Morten Kranker Larsen, Lea Løffler, Camilla Andersen, Isabella Davidsen, Mette Grymer Jensen, Jonas Bechlund, Lasse Kjær, Vibe Skov, Henning Bay Nielsen, Carsten Lundby   +10 more
wiley   +1 more source